Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,838 | -9,342 | -5,113 | -32,084 | -17,350 |
| Depreciation Amortization | 927 | 582 | 262 | 759 | 530 |
| Accounts receivable | -1,243 | -388 | -658 | 140 | -264 |
| Accounts payable and accrued liabilities | N/A | 254 | N/A | N/A | N/A |
| Other Working Capital | -991 | -215 | -732 | 986 | -151 |
| Other Operating Activity | 3,369 | 1,662 | 2,434 | 19,750 | 10,238 |
| Operating Cash Flow | $-13,776 | $-7,447 | $-3,807 | $-10,449 | $-6,997 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -175 | N/A | N/A | N/A | N/A |
| PPE Investments | -2,643 | -1,904 | -817 | -2,324 | -1,062 |
| Other Investing Activity | -123 | -81 | -39 | -114 | -75 |
| Investing Cash Flow | $-2,941 | $-1,985 | $-856 | $-2,438 | $-1,137 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | -53 | -53 | -17 | 58,670 | 12,913 |
| Other Financing Activity | 0 | 0 | 0 | -104 | -125 |
| Financing Cash Flow | $-53 | $-53 | $-17 | $58,566 | $12,788 |
| Exchange Rate Effect | 1,002 | 1,032 | 649 | 756 | 408 |
| Beginning Cash Position | 61,813 | 61,813 | 61,813 | 15,378 | 15,378 |
| End Cash Position | 46,045 | 53,360 | 57,782 | 61,813 | 20,440 |
| Net Cash Flow | $-15,768 | $-8,453 | $-4,031 | $46,435 | $5,062 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,776 | -7,447 | -3,807 | -10,449 | -6,997 |
| Capital Expenditure | -2,643 | -1,904 | -817 | -2,335 | -1,072 |
| Free Cash Flow | -16,419 | -9,351 | -4,624 | -12,784 | -8,069 |